Covid-19 response

COVID-19 response

In response to the COVID-19 pandemic the company sought to identify ways in which it could support the collective research efforts to better understand the impact of the infection on patients with long term conditions. In 2020 the company launched two clinical research studies in the UK and US to investigate the association between high blood pressure, therapy regimen and COVID-19 infection. The results of this work are still undergoing analysis.

The company has formally moved to a remote working environment to support our colleagues to stay safe during the pandemic.